Show simple item record

Barrett's esophagus: natural history

dc.contributor.authorAppelman, Henry D.en_US
dc.contributor.authorUmar, Asaden_US
dc.contributor.authorOrlando, Roy C.en_US
dc.contributor.authorSontag, Stephen J.en_US
dc.contributor.authorNandurkar, Sanjayen_US
dc.contributor.authorEl‐zimaity, Halaen_US
dc.contributor.authorLanas, Angelen_US
dc.contributor.authorParise, Paoloen_US
dc.contributor.authorLambert, Renéen_US
dc.contributor.authorShields, Helen M.en_US
dc.date.accessioned2011-11-10T15:31:43Z
dc.date.available2012-11-02T18:56:29Zen_US
dc.date.issued2011-09en_US
dc.identifier.citationAppelman, Henry D.; Umar, Asad; Orlando, Roy C.; Sontag, Stephen J.; Nandurkar, Sanjay; El‐zimaity, Hala ; Lanas, Angel; Parise, Paolo; Lambert, René ; Shields, Helen M. (2011). "Barrett's esophagus: natural history." Annals of the New York Academy of Sciences 1232(1). <http://hdl.handle.net/2027.42/86834>en_US
dc.identifier.issn0077-8923en_US
dc.identifier.issn1749-6632en_US
dc.identifier.urihttps://hdl.handle.net/2027.42/86834
dc.publisherBlackwell Publishing Incen_US
dc.publisherWiley Periodicals, Inc.en_US
dc.subject.otherRefluxen_US
dc.subject.otherAdenocarcinomaen_US
dc.subject.otherCDX2en_US
dc.subject.otherDilated Intercellular Spacesen_US
dc.subject.otherBile Saltsen_US
dc.subject.otherHigh‐Grade Dysplasiaen_US
dc.subject.otherBarrett's Esophagusen_US
dc.subject.otherBiopsy Protocolen_US
dc.subject.otherAdenocarcinomaen_US
dc.subject.otherGastric Atrophyen_US
dc.subject.otherH. Pylorien_US
dc.subject.otherGERDen_US
dc.subject.otherEndoscopic Grading Systemen_US
dc.subject.otherCag A‐Postive Strainen_US
dc.subject.otherMetaplasiaen_US
dc.subject.otherLaparoscopic Surgeryen_US
dc.subject.otherHigh Resolution Endoscopyen_US
dc.subject.otherNarrow Band Imagingen_US
dc.subject.otherTrimodal Technologyen_US
dc.subject.otherBimodal Protocolen_US
dc.subject.otherEsophageal Metaplasiaen_US
dc.subject.otherRadiofrequency Ablationen_US
dc.subject.otherEndoscopic Mucosal Resectionen_US
dc.subject.otherInterobserver Reproducibilityen_US
dc.titleBarrett's esophagus: natural historyen_US
dc.typeArticleen_US
dc.rights.robotsIndexNoFollowen_US
dc.subject.hlbsecondlevelScience (General)en_US
dc.subject.hlbtoplevelScienceen_US
dc.description.peerreviewedPeer Revieweden_US
dc.contributor.affiliationumDepartment of Pathology, University of Michigan, Ann Arbor, Michigan.en_US
dc.contributor.affiliationotherDivision of Cancer Prevention, National Cancer Institute, Rockville, Maryland.en_US
dc.contributor.affiliationotherDepartment of Cell and Molecular Physiology, University of North Carolina School of Medicine, Chapel Hill, North Carolina.en_US
dc.contributor.affiliationotherVeterans Administration Hospital, Hines, Illinois.en_US
dc.contributor.affiliationotherDepartment of Gastroenterology, Box Hill Hospital, Box Hill, VIC, Australia.en_US
dc.contributor.affiliationotherUniversity Health Network, Anatomic Pathology, Toronto General Hospital, Toronto, Canada.en_US
dc.contributor.affiliationotherDepartment of Digestive Diseases, University of Zaragoza, Aragón Health Research Institute, CIBERehd, Zaragoza, Spain.en_US
dc.contributor.affiliationotherDepartment of General Surgery IV, Regional Referal Center for Esophageal Pathology, Pisa, Italy.en_US
dc.contributor.affiliationotherInternational Agency for Research on Cancer, Lyon, France.en_US
dc.contributor.affiliationotherGastroenterology Division, Harvard Medical School and Beth Israel Deaconess Medical Center, Boston, Massachusettsen_US
dc.identifier.pmid21950819en_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/86834/1/j.1749-6632.2011.06057.x.pdf
dc.identifier.doi10.1111/j.1749-6632.2011.06057.xen_US
dc.identifier.sourceAnnals of the New York Academy of Sciencesen_US
dc.identifier.citedreferenceKahrilas, P.J. & J.E. Pandolfino. 2002. Gastroesophageal reflux disease and its complications, including Barrett's metaplasia. In Sleisenger and Fordtran's Gastrointestinal and Liver Disease: Pathophysiology/Diagnosis/Management. Chapter 33. M. Feldman, L.S. Friedman & M.H. Sleisenter, Eds.: 616. Saunders. Philadelphia.en_US
dc.identifier.citedreferenceSpechler, S.J., R.C. Fitzgerald, G.A. Prasad & K.K. Wang. 2010. History, molecular mechanisms, and endoscopic treatment of Barrett's esophagus. Gastroenterol 138: 854 – 859.en_US
dc.identifier.citedreferenceSociety of Thoracic Surgeons, website, http://www.sts.org/. 2010.en_US
dc.identifier.citedreferenceBlot, W.J. & J.F. Fraumeni, Jr. 1987. Trends in esophageal cancer mortality among US blacks and whites. Am. J. Public Health 77: 296 – 298.en_US
dc.identifier.citedreferencePolednak, A.P. 2003. Trends in survival for both histologic types of esophageal cancer in US surveillance, epidemiology and end results areas. Int. J. Cancer 105: 98 – 100.en_US
dc.identifier.citedreferenceCamilleri, M., D. Dubois, B. Coulie, et al. 2005. Prevalence and socioeconomic impact of upper gastrointestinal disorders in the United States: results of the US Upper Gastrointestinal Study. Clin. Gastroenterol. Hepatol. 3: 543 – 552.en_US
dc.identifier.citedreferenceHayeck, T.J., C.Y. Kong, S.J. Spechler, et al. The prevalence of Barrett's esophagus in the US: estimates from a simulation model confirmed by SEER data. Dis. Esophagus, 23: 451 – 457.en_US
dc.identifier.citedreferenceGerson, L.B., R. Edson, P.W. Lavori & G. Triadafilopoulos. 2001. Use of a simple symptom questionnaire to predict Barrett's esophagus in patients with symptoms of gastroesophageal reflux. Am. J. Gastroenterol. 96: 2005 – 2012.en_US
dc.identifier.citedreferenceRonkainen, J., P. Aro, T. Storskrubb, et al. 2005. Prevalence of Barrett's esophagus in the general population: an endoscopic study. Gastroenterology 129: 1825 – 1831.en_US
dc.identifier.citedreferenceOberg, S., J. Johansson, J. Wenner & B. Walther. 2002. Metaplastic columnar mucosa in the cervical esophagus after esophagectomy. Ann. Surg. 235: 338 – 345.en_US
dc.identifier.citedreferenceSu, Y., X. Chen, M. Klein, et al. 2004. Phenotype of columnar‐lined esophagus in rats with esophagogastroduodenal anastomosis: similarity to human Barrett's esophagus. Lab. Invest. 84: 753 – 765.en_US
dc.identifier.citedreferenceSouza, R.F., K. Krishnan & S.T. Spechler. 2008. Acid, bile, and CDX: the ABCs of making Barrett's metaplasia. Am. J. Physiol. Gastrointest. Liver Physiol. 295: G211 – G218.en_US
dc.identifier.citedreferenceAlvaro‐Villegas, J.C., S. Sobrino‐Cossio, A. Hernandez‐Guerrero, et al. Dilated intercellular spaces in subtypes of gastroesophagic reflux disease. Rev. Esp. Enferm. Dig. 102: 302 – 307.en_US
dc.identifier.citedreferenceAbela, J.‐E., J.J. Going, J.F. Mackenzie, et al. 2008. Systematic four‐quadrant biopsy detects Barrett's dysplasia in more patients than nonsystematic biopsy. Am. J. Gastroenterol. 103: 850 – 855.en_US
dc.identifier.citedreferenceAjumobi, A., K. Bahjri, C. Jackson & R. Griffin. 2010. Surveillance in Barrett's esophagus: an audit of practice. Dig. Dis. Sci. 55: 1615 – 1621.en_US
dc.identifier.citedreferenceKomanduri, S., G. Swanson, L. Keefer & S. Jakate. 2009. Use of a new jumbo forceps improves tissue acquisition of Barrett's esophagus surveillance biopsies. Gastrointest. Endosc. 70: 1072 – 1078.en_US
dc.identifier.citedreferenceReid, B.J., P.L. Blount, Z. Feng & D.S. Levine. 2000. Optimizing endoscopic biopsy detection of early cancer in Barrett's high‐grade dysplasia. Am. J. Gastroenterol. 95: 3089 – 3096.en_US
dc.identifier.citedreferenceManath, J., V. Subramanian, J. Hawkey & K. Ragunath. 2010. Narrow band imaging for characterization of high‐grade dysplasia and specialized intestinal metaplasia in Barrett's esophagus: a meta analysis. Endoscopy 42: 351 – 359.en_US
dc.identifier.citedreferenceBlaser, M.J. 1999. Hypothesis: the changing relationships of  Helicobacter pylori  and humans: implications for health and disease. J Infect Dis. 179: 1523 – 1530.en_US
dc.identifier.citedreferenceAbe, Y., K. Iijima, T. Koike, et al. 2009. Barrett's esophagus is characterized by the absence of  Helicobacter pylori  infection and high levels of serum pepsinogen I concentration in Japan. J. Gastroenterol. Hepatol. 24: 129 – 134.en_US
dc.identifier.citedreferenceKimura, K. 1973. Chronological changes of atrophic gastritis. Nippon Shokakibyo Gakkai Zasshi. 70: 307 – 315.en_US
dc.identifier.citedreferenceKim, D.H., G.H. Kim, J.Y. Kim, et al. 2007. Endoscopic grading of atrophic gastritis is inversely associated with gastroesophageal reflux and gastropharyngeal reflux. Korean J. Intern. Med. 22: 231 – 236.en_US
dc.identifier.citedreferenceEl‐Zimaity, H.M., H. Ota, D.Y. Graham, et al. 2002. Patterns of gastric atrophy in intestinal type gastric carcinoma. Cancer 94: 1428 – 1436.en_US
dc.identifier.citedreferenceRokkas T., D. Pistiolas, P. Sechopoulos, et al. 2007. Relationship between  Helicobacter pylori  infection and esophageal neoplasia: a meta‐analysis. Clin Gastroenterol. Hepatol. 5: 1413 – 1417.en_US
dc.identifier.citedreferenceWang, C., Y. Yuan & R.H. Hunt. 2009. Helicobacter pylori  infection and Barrett's esophagus: a systematic review and meta‐analysis. Am. J. Gastroenterol. 104: 492 – 500.en_US
dc.identifier.citedreferenceMccoll, K.E. 2007. Helicobacter pylori  and oesophageal cancer–not always protective. Gut. 56: 457 – 459.en_US
dc.identifier.citedreferenceAxon, A.T. 2004. Personal view: to treat or not to treat?  Helicobacter pylori  and gastro‐oesophageal reflux disease—an alternative hypothesis. Aliment. Pharmacol. Ther. 19: 253 – 261.en_US
dc.identifier.citedreferenceHoltmann, G., C. Cain & P. Malfertheiner. 1999. Gastric  Helicobacter pylori  infection accelerates healing of reflux esophagitis during treatment with the proton pump inhibitor pantoprazole. Gastroenterology 117: 11 – 16.en_US
dc.identifier.citedreferenceYachida, S., D. Saito, T. Kozu, et al. 2001. Endoscopically demonstrable esophageal changes after  Helicobacter pylori  eradication in patients with gastric disease. J. Gastroenterol. Hepatol. 16: 1346 – 1352.en_US
dc.identifier.citedreferencePeters, F.T., E.J. Kuipers, S. Ganesh, et al. 1999. The influence of  Helicobacter pylori  on oesophageal acid exposure in GERD during acid suppressive therapy. Aliment. Pharmacol. Ther. 13: 921 – 926.en_US
dc.identifier.citedreferenceRaghunath, A.S., A.P. Hungin, D. Wooff & S. Childs. 2004. Systematic review: the effect of  Helicobacter pylori  and its eradication on gastro‐oesophageal reflux disease in patients with duodenal ulcers or reflux oesophagitis. Aliment. Pharmacol. Ther. 20: 733 – 744.en_US
dc.identifier.citedreferenceKuipers, E.J., G.F. Nelis, E.C. Klinkenberg‐Knol, et al. 2004. Cure of  Helicobacter pylori  infection in patients with reflux oesophagitis treated with long term omeprazole reverses gastritis without exacerbation of reflux disease: results of a randomised controlled trial. Gut. 53: 12 – 20.en_US
dc.identifier.citedreferenceWang, K.K. & R.E. Sampliner. 2008. Updated guidelines 2008 for the diagnosis, surveillance and therapy of Barrett's esophagus. Am. J. Gastroenterol. 103: 788 – 797.en_US
dc.identifier.citedreferenceSpechler, S.J., A.H. Robbins, et al. 1984. Adenocarcinoma and Barrett’esophagus: an overrated risk Gastroenterology 87: 927 – 933.en_US
dc.identifier.citedreferenceCameron, A.J., B.J. Ott, et al. 1985. The incindence of adenocarcinoma in columnar‐lined (Barrett's) esophagus. N. Engl. J. Med. 313: 857 – 859.en_US
dc.identifier.citedreferenceWeston, A.P., A.S. Badr, et al. 1999. Prospective multivariate analysis of clinical, endoscopic, and histological factors predictive of the development of Barrett's multifocal high‐grade dysplasia or adenocarcinoma. Am. J. Gastroenterol. 94: 3413 – 3419.en_US
dc.identifier.citedreferenceHage, M., D. Siersema, et al. 2004. Oesophageal cancer incidence and mortality in patients with long‐segment Barrett's oesophagus after a mean follow‐up of 12,7 years. Scand. J. Gastroenterol. 12: 1175 – 1179.en_US
dc.identifier.citedreferencePeters, F.T., S. Ganesh, et al. 1999. Endoscopic regression of Barrett's esophagus during omeprazole treatment: a randomized double‐blind study. Gut. 45: 489 – 494.en_US
dc.identifier.citedreferenceGurski, R., J.H. Peters, et al. 2003. Barrett's esophagus can and does regress after antireflux surgery: a study of prevalence and predictive features. J. Am. Coll. Surg. 196: 706 – 712.en_US
dc.identifier.citedreferenceCsendes, A., I. Braghetto, et al. 2009. Late results of surgical treatments of 125 patients with short‐segment Barrett's esophagus. Arch. Surg. 144: 921 – 927.en_US
dc.identifier.citedreferenceHofstetter, W.L., J.H. Peters, et al. 2001. Long‐term outcome of anti‐reflux surgery in patients with Barrett's esophagus. Ann. Surg. 234: 532 – 539.en_US
dc.identifier.citedreferenceParrilla, P., L.F. Martinez de Haro, et al. 2003. Long‐term results of a randomized prospective study comparing medical and surgical treatment of Barrett's esophagus. Ann. Surg. 237: 291 – 298.en_US
dc.identifier.citedreferenceRossi, M., M. Barreca, et al. 2006. Efficacy of Nissen fundoplication versus medical therapy in the regression of low‐grade dysplasia in patients with Barrett esophagus. A prospective study. Ann. Surg. 243: 58 – 63.en_US
dc.identifier.citedreferenceMartinez de Haro, L., A. Ortiz, et al. 2001. Intestinal metaplasia in patients with columnar lined esophagus is associated with high levels of duodenogastroesphageal reflux. Ann. Surg. 233: 34 – 38.en_US
dc.identifier.citedreferenceTodd, J.A., K.K. Basu, et al. 2005. Normalisation of oesophageal pH does not guatantee control of duodenogastro‐esophageal reflux in Barrett's esophagus. Aliment. Pharmacol. Ther. 21: 969 – 975.en_US
dc.identifier.citedreferenceChang, E.Y., C.D. Morris, et al. 2007. The effect of antireflux surgery on esophageal carcinogenesis in patients with Barrett's esophagus. Ann. Surg. 246: 11 – 21.en_US
dc.identifier.citedreferenceCorey, K.E., S.M. Schmitz, et al. 2003. Does a surgical antireflux procedure decrease the incidence of esophageal adenocarcinoma in Barrett's esophagus? A meta‐analysis. Am. J. Gastroenterol. 98: 2390 – 2394.en_US
dc.identifier.citedreferenceLambert, R. & P. Hainaut. 2007. Esophageal cancer: the precursors (Part II). Endoscopy 39: 659 – 664.en_US
dc.identifier.citedreferenceSingh, R., G.K. Anagnostopoulos, K. Yao, et al. 2008. Narrow‐band imaging with magnification in Barrett's esophagus: validation of a simplified grading system of mucosal morphology patterns against histology. Endoscopy 40: 457 – 463.en_US
dc.identifier.citedreferenceMannath, J., V. Subramanian, C.J. Hawkey, et al. 2010. Narrow band imaging for characterization of high‐grade dysplasia and specialized intestinal metaplasia in Barrett's esophagus: a meta‐analysis. Endoscopy 42: 351 – 359.en_US
dc.identifier.citedreferenceKara, M.A., F.P. Peters, P. Fockens, et al. 2006. Endoscopic video‐autofluorescence imaging followed by narrow band imaging for detecting early neoplasia in Barrett's esophagus. Gastrointest. Endosc. 64: 176 – 185.en_US
dc.identifier.citedreferenceCurvers, W.L., L.A. Herrero, M.B. Wallace, et al. 2010. Endoscopic tri‐modal imaging is more effective than standard endoscopy in targeting early‐stage neoplasia in Barrett's esophagus. Gastroenterology [Epub ahead of print.en_US
dc.identifier.citedreferenceMaru, D.M. 2009. Barrett's esophagus: diagnostic challenges and recent developments. Ann. Diag. Path. 13: 212 – 221.en_US
dc.identifier.citedreferenceReid, B.J., D.S. Levine, G. Longton, et al. 2000. Predictors of progression to cancer in Barrett's esophagus: baseline histology and flow cytometry identify low‐ and high‐risk patient subsets. Am. J. Gastroenterol. 95: 1669 – 1676.en_US
dc.identifier.citedreferenceSchnell, T.G., S.J. Sontag, G. Chejfec, et al. 2001. Long‐term nonsurgical management of Barrett's esophagus with high‐grade dysplasia. Gastroenterology 120: 1607 – 1619.en_US
dc.identifier.citedreferenceEll, C., A. May, L. Grossner, et al. 2000. Endoscopic mucosal resection for early cancer and high‐grade dysplasia in Barrett's esophagus. Gastroenterology 118: 670 – 677.en_US
dc.identifier.citedreferenceShaheen, N.J., P. Sharma, B.F. Overholt, et al. 2009. Radiofrequency ablation in Barrett's esophagus with dysplasia. N. Engl. J. Med. 360: 2277 – 2288.en_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.